GBP1 and head and neck cancer: Guanylate-binding protein 1 (GBP1), an interferon-stimulated gene induced by interferon-gamma (IFN-γ), has been implicated in tumor progression and treatment resistance in various cancers, including ovarian and head and neck cancers [9].